Post by
curiousbuild on Mar 23, 2016 7:03pm
Kevin oleary
suggested the short at 52wk low and buy the bonds last week. LMAO. He should track his own etfs performances. CB
Comment by
biggerr on Mar 23, 2016 8:29pm
Valeant Pharmaceuticals (VRX-NYSE; VRX-TSX) Rating: Market Perform Target Price: $66.00 Total Return: 145% Price (18-Mar): $26.98 March 21, 2016 Alex Arfaei BMO Nesbitt Burns Inc. 212-885-4033 / 416-359-4
Comment by
BSmartStaycalm on Mar 23, 2016 8:50pm
I have ZERO respect for the blow hard leach! Got lucky and now sucks the blood out of everything around him, thinks far too much of himself!
Comment by
notwrong on Mar 24, 2016 12:36am
This post has been removed in accordance with Community Policy